Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Video Credit: Wochit News
Published on June 30, 2020 - Duration: 00:35s

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug thatโ€™s been approved for COVID emergencies.

The FDA officially announced the medicine could be used in treating COVID-19 patients.

Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals.

Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients.

It could shorten satsy by several days, reports Gizmodo.


You are here

๐Ÿ’ก One News Page Knowledge: Other News Mentions

Gilead Sciences

American pharmaceutical company
Government clearance of the emergency treatment, which will be called Veklury, would open the door to wider usage.
Credit: CBS News - Published 11 hours ago

California, Louisiana and other attorneys general say Gilead Sciences' antiviral should be licensed to others to ease potential shortages, lower price
Credit: USATODAY.com - Published 1 week ago

Food and Drug Administration

Agency of the United States Department of Health and Human Services
The former FDA commissioner says the U.S. is "definitely going to be somewhere between 200,000 and 300,000" deaths depending on mitigation efforts.
Credit: CBS News - Published 2 days ago

The FDA, USDA and CDC are investigating an onion-linked salmonella outbreak that has grown to 640 illnesses and 85 hospitalizations in 43 states.
Credit: USATODAY.com - Published 3 days ago

The agency has moved to keep several of the products, which it found to have inadequate concentrations of alcohol, from entering the United States.
Credit: NYTimes.com - Published 1 week ago

Related videos from verified sources

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient 00:45
Video credit: Geo Beats - Published on June 29, 2020 

You might like